| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |